These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 23377739)

  • 1. The problem of late ART initiation in Sub-Saharan Africa: a transient aspect of scale-up or a long-term phenomenon?
    Lahuerta M; Ue F; Hoffman S; Elul B; Kulkarni SG; Wu Y; Nuwagaba-Biribonwoha H; Remien RH; El Sadr W; Nash D
    J Health Care Poor Underserved; 2013 Feb; 24(1):359-83. PubMed ID: 23377739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review.
    Adejumo OA; Malee KM; Ryscavage P; Hunter SJ; Taiwo BO
    J Int AIDS Soc; 2015; 18(1):20049. PubMed ID: 26385853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric Access and Continuity of HIV Care Before the Start of Antiretroviral Therapy in Sub-Saharan Africa.
    Bastard M; Poulet E; Nicolay N; Szumilin E; Balkan S; Pujades-Rodriguez M
    Pediatr Infect Dis J; 2016 Sep; 35(9):981-6. PubMed ID: 27187757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with late antiretroviral therapy initiation among adults in Mozambique.
    Lahuerta M; Lima J; Nuwagaba-Biribonwoha H; Okamura M; Alvim MF; Fernandes R; Assan A; Hoos D; Elul B; El-Sadr WM; Nash D
    PLoS One; 2012; 7(5):e37125. PubMed ID: 22615917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
    Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
    AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Family matters: Co-enrollment of family members into care is associated with improved outcomes for HIV-infected women initiating antiretroviral therapy.
    Myer L; Abrams EJ; Zhang Y; Duong J; El-Sadr WM; Carter RJ
    J Acquir Immune Defic Syndr; 2014 Dec; 67 Suppl 4(Suppl 4):S243-9. PubMed ID: 25436824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with late antiretroviral therapy initiation in Cameroon: a representative multilevel analysis.
    Ndawinz JD; Chaix B; Koulla-Shiro S; Delaporte E; Okouda B; Abanda A; Tchomthe S; Mboui E; Costagliola D; Supervie V
    J Antimicrob Chemother; 2013 Jun; 68(6):1388-99. PubMed ID: 23391713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of ART on the fertility of HIV-positive women in sub-Saharan Africa.
    Yeatman S; Eaton JW; Beckles Z; Benton L; Gregson S; Zaba B
    Trop Med Int Health; 2016 Sep; 21(9):1071-85. PubMed ID: 27371942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond "Option B+": Understanding Antiretroviral Therapy (ART) Adherence, Retention in Care and Engagement in ART Services Among Pregnant and Postpartum Women Initiating Therapy in Sub-Saharan Africa.
    Myer L; Phillips TK
    J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S115-S122. PubMed ID: 28498180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study.
    Desmonde S; Tanser F; Vreeman R; Takassi E; Edmonds A; Lumbiganon P; Pinto J; Malateste K; McGowan C; Kariminia A; Yotebieng M; Dicko F; Yiannoutsos C; Mubiana-Mbewe M; Wools-Kaloustian K; Davies MA; Leroy V;
    PLoS Med; 2018 May; 15(5):e1002565. PubMed ID: 29727458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cascade of Refusal-What Does It Mean for the Future of Treatment as Prevention in Sub-Saharan Africa?
    Katz IT; Bangsberg DR
    Curr HIV/AIDS Rep; 2016 Apr; 13(2):125-30. PubMed ID: 26894487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with initiation of antiretroviral therapy in the advanced stages of HIV infection in six Ethiopian HIV clinics, 2012 to 2013.
    Nash D; Tymejczyk O; Gadisa T; Kulkarni SG; Hoffman S; Yigzaw M; Elul B; Remien RH; Lahuerta M; Daba S; El Sadr W; Melaku Z
    J Int AIDS Soc; 2016; 19(1):20637. PubMed ID: 27113335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The REVAMP trial to evaluate HIV resistance testing in sub-Saharan Africa: a case study in clinical trial design in resource limited settings to optimize effectiveness and cost effectiveness estimates.
    Siedner MJ; Bwana MB; Moosa MS; Paul M; Pillay S; McCluskey S; Aturinda I; Ard K; Muyindike W; Moodley P; Brijkumar J; Rautenberg T; George G; Johnson B; Gandhi RT; Sunpath H; Marconi VC
    HIV Clin Trials; 2017 Jul; 18(4):149-155. PubMed ID: 28720039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysis.
    Siedner MJ; Ng CK; Bassett IV; Katz IT; Bangsberg DR; Tsai AC
    Clin Infect Dis; 2015 Apr; 60(7):1120-7. PubMed ID: 25516189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does early ART in sub-Saharan Africa decrease mortality?
    Katz IT; Siedner MJ
    Lancet HIV; 2015 Sep; 2(9):e354-5. PubMed ID: 26423540
    [No Abstract]   [Full Text] [Related]  

  • 16. Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis.
    Mugglin C; Estill J; Wandeler G; Bender N; Egger M; Gsponer T; Keiser O;
    Trop Med Int Health; 2012 Dec; 17(12):1509-20. PubMed ID: 22994151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing Infant HIV Diagnosis in Resource-Limited Settings: Modeling the Impact of HIV DNA PCR Testing at Birth.
    Chiu A; Modi S; Rivadeneira ED; Koumans EH
    J Acquir Immune Defic Syndr; 2016 Dec; 73(4):454-462. PubMed ID: 27792684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twelve-year mortality in adults initiating antiretroviral therapy in South Africa.
    Cornell M; Johnson LF; Wood R; Tanser F; Fox MP; Prozesky H; Schomaker M; Egger M; Davies MA; Boulle A;
    J Int AIDS Soc; 2017 Sep; 20(1):21902. PubMed ID: 28953328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of dropout from care among HIV-infected patients initiating antiretroviral therapy at a public sector HIV treatment clinic in sub-Saharan Africa.
    Asiimwe SB; Kanyesigye M; Bwana B; Okello S; Muyindike W
    BMC Infect Dis; 2016 Feb; 16():43. PubMed ID: 26832737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review.
    Kranzer K; Govindasamy D; Ford N; Johnston V; Lawn SD
    J Int AIDS Soc; 2012 Nov; 15(2):17383. PubMed ID: 23199799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.